YD Bio (NASDAQ:YDES) Shares Gap Up – Here’s What Happened

YD Bio Limited (NASDAQ:YDES)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $9.03, but opened at $9.46. YD Bio shares last traded at $9.20, with a volume of 6,447 shares traded.

Analyst Upgrades and Downgrades

A number of analysts have commented on YDES shares. Weiss Ratings reiterated a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen upgraded YD Bio to a “sell” rating in a research report on Tuesday, November 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, YD Bio currently has an average rating of “Sell”.

YD Bio Stock Performance

The stock has a 50 day moving average price of $11.11.

Institutional Investors Weigh In On YD Bio

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its stake in YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.